Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Berinert Antibody Formation in HAE
NCT01467947Phase 4Completed
- Sponsor
- CSL Limited
- Start
- Nov 2011
- Primary completion
- Oct 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 4
01
Overview
Phase 4, open-label, single-arm trial of c1-esterase inhibitor in hereditary angioedema (HAE), sponsored by CSL Limited. Primary endpoint: Number of Subjects With Inhibitory Anti-C1-esterase-inhibitor Antibodies at 9 months. Started Nov 2011; status: completed.
02
Drugs
c1-esterase inhibitor
03
Conditions
hereditary angioedema (HAE)
Beyond the preview
Go deeper on NCT01467947.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01467947.